Healthcare
MediPal Holdings Corporation(MAHLY)
Live Price
Offline$15.74
+0.00% today
1Y Change
+2.13%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $576.23B
- Revenue Growth
- +3.2%
- EPS Growth
- -1.3%
- Dividend Yield
- 2.3%
Coverage: 250 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
MediPal Holdings Corporation (MAHLY) is a Healthcare stock with a market cap of $576.23B and listed on OTC. The stock last traded around $15.74 and up 2.1% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +3.2%, EPS growth of -1.3%, a dividend yield of 2.3%. What stands out right now is revenue +3.2%, EPS -1.3%, free cash flow +13.4% with operating margin 1.4% and ROIC 4.3%. The dividend is present but secondary, with a yield around 2.3%. Valuation is more restrained than many high-expectation growth names at P/E 13.9 and price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MAHLY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.2% vs +7.6% peer median
Operating Margin
Below sector median
+1.4% vs +19.4% peer median
P/E
Below sector median
13.9 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +3.2% and EPS is at -1.3%, with operating margin around 1.4%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.3%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.4% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | +0.0% | +0.3% | +0.3% |
2026 Feb 9, 2026 | โ | +0.0% | +5.4% | -0.9% |
2025 Oct 30, 2025 | โ | +0.0% | -1.4% | +7.2% |
Benchmark Edge
MAHLY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MAHLY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MAHLY Max Drawdown
-24.47%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MAHLY and SPY.
Company Overview
MediPal Holdings Corporation
Other OTC
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
- Leadership
- Shuichi Watanabe
- IPO Date
- Oct 6, 2009
- Employees
- 13.1k
- Street Address
- 2-7-15, Yaesu
- Mailing
- Tokyo, 104-8461
- Region
- Tokyo, JP
- Reporting Currency
- USD
- Investor Line
- 81 3 3517 5800
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 13.9
- EV/EBITDA
- 4.8
- Price/Sales
- 0.2
- Price/Book
- 0.9
Growth
- Revenue
- +3.2%
- EPS
- -1.3%
- Free Cash Flow
- +13.4%
Profitability
- Gross Margin
- 6.5%
- Operating Margin
- 1.4%
- Net Margin
- 1.1%
- ROE
- 6.6%
- ROIC
- 4.3%
Balance Sheet
- Debt/Equity
- 0.07
- Current Ratio
- 1.25
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.